Insider · CIK 0001333516
Kim R Tsuchimoto
Files at MNPR (Monopar Therapeutics). First filing Jul 16, 2025, latest Jul 16, 2025.
Kim R Tsuchimoto files SEC Form 4 as director at MNPR (Monopar Therapeutics). Since Jul 16, 2025, Kim R Tsuchimoto has reported 0 open-market buys worth $0 and 1 open-market sell worth $356k, the latest filed on Jul 16, 2025.
A track record needs three past buys with six months of prices behind them; Kim R Tsuchimoto has 0, so none is measured yet.
The newest scored trade: sold $356k of MNPR on Jul 14, 2025, filed Jul 16, 2025, scored 55 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MNPR: Monopar Therapeutics
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Monopar Therapeutics | $356k 8,904 shares | -44% | +1722% from low-16% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 14, 2025 | MNPR Monopar Therapeutics | 8,904 0.15% of outstanding | $356k | Jul 14, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | MNPR Monopar Therapeutics | AGrant or award Stock Optionsderivative | +2,924 | $0.00 | $0 | 2,924 | Dec 8, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | XIn-the-money exercise Common Stock | +8,904 | $0.01 | $45 | 20,390 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | SOpen-market sale Common Stock | -8,904 | $40.00 | $356k | 11,486 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | XIn-the-money exercise Stock Optionsderivative | -4,200 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jul 14, 2025 | MNPR Monopar Therapeutics | XIn-the-money exercise Stock Optionsderivative | -4,704 | $0.00 | $0 | 0 | Jul 16, 2025 |
Questions about Kim R Tsuchimoto
Answered from the filings on this page, as of the latest one.
Is Kim R Tsuchimoto buying or selling?
Not in the last 12 months. Kim R Tsuchimoto's latest open-market trade on SEC Form 4 was sold $356k of MNPR on Jul 14, 2025.
How did Kim R Tsuchimoto's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kim R Tsuchimoto has 0.
Where does Kim R Tsuchimoto file Form 4?
Kim R Tsuchimoto has filed Form 4 at MNPR (Monopar Therapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.